Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Presystemic and systemic glucuronidation of propranolol.

T Walle, T C Fagan, E C Conradi

    Clinical Pharmacology and Therapeutics
    |August 1, 1979
    PubMed
    Summary

    Glucuronidation significantly impacts propranolol bioavailability. This study shows that glucuronidation is a key factor in how the body processes oral propranolol, influencing its absorption and availability.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Cytotoxic effects of the dietary flavones chrysin and apigenin in a normal trout liver cell line.

    Chemico-biological interactions·2007
    Same author

    Methylation protects dietary flavonoids from rapid hepatic metabolism.

    Xenobiotica; the fate of foreign compounds in biological systems·2006
    Same author

    S-adenosyl-L-methionine: transcellular transport and uptake by Caco-2 cells and hepatocytes.

    The Journal of pharmacy and pharmacology·2005
    Same author

    Familial and sporadic inflammatory bowel disease: comparison of clinical features and serological markers in a genetically homogeneous population.

    Scandinavian journal of gastroenterology·2002
    Same author

    Transport and metabolism of the tea flavonoid (-)-epicatechin by the human intestinal cell line Caco-2.

    Pharmaceutical research·2001
    Same author

    Cardiovascular safety of sublingual apomorphine in patients on stable doses of oral antihypertensive agents and nitrates.

    The American journal of cardiology·2001

    Area of Science:

    • Pharmacokinetics
    • Drug Metabolism

    Background:

    • Propranolol is a widely used beta-blocker with significant first-pass metabolism.
    • Understanding the metabolic pathways of propranolol is crucial for optimizing its therapeutic efficacy.

    Purpose of the Study:

    • To determine the relative contribution of presystemic and systemic glucuronidation to propranolol metabolism.
    • To assess the impact of glucuronidation on propranolol bioavailability after oral and intravenous administration.

    Main Methods:

    • Single oral and intravenous doses of propranolol were administered to healthy subjects.
    • Plasma concentrations of propranolol and its glucuronide metabolite (PG) were measured over time.
    • Area Under the Curve (AUC) was calculated to quantify drug exposure.

    Related Experiment Videos

    Main Results:

    • After intravenous administration, AUCs of PG and propranolol were similar.
    • Following oral doses, AUCs of PG were approximately seven times higher than propranolol.
    • Peak concentrations and half-lives for both propranolol and PG were comparable.

    Conclusions:

    • Glucuronidation is a major pathway for propranolol metabolism, particularly after oral administration.
    • Presystemic glucuronidation significantly reduces propranolol bioavailability.
    • Glucuronidation is a critical determinant of propranolol's systemic availability.